ConductScience.org, home

Paper25019388

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

Clark MP and 41 others. J Med Chem, 2014. Cited by 188 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. Papers, record 25019388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25019388

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
PubMed
Journal
J Med Chem
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
188
iCite
Relative citation ratio, by iCite
6.13
iCite
Revised in PubMed
2020-12-09
PubMed

Authors42

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark MPMichael P
2Ledeboer MWMark W
3Davies IIoana
4Byrn RARandal A
5Jones SMSteven M
6Perola EEmanuele
7Tsai AAlice
8Jacobs MMarc
9Nti-Addae KKwame
10Bandarage UKUpul K
11Boyd MJMichael J
12Bethiel RSRandy S
13Court JJJohn J
14Deng HHongbo
15Duffy JPJohn P
16Dorsch WAWarren A
17Farmer LJLuc J
18Gao HHuai
19Gu WWenxin
20Jackson KKatrina

Source PubMed

See all 42 authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Aza CompoundsMajor topic
IndolesMajor topic
RNA-Dependent RNA PolymeraseMajor topic
Viral ProteinsMajor topic
Administration, Oral
Animals
Biological Availability
Dogs
Drug Resistance, Viral
Influenza A virus
Madin Darby Canine Kidney Cells
Male
Mice, Inbred BALB C
Models, Molecular
Molecular Structure
Orthomyxoviridae Infections
Rats
Species Specificity
Stereoisomerism
Structure-Activity Relationship
Virus Replication

Source PubMed

Cited by99

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.

PMIDTitleJournalYearIn PapersSource
42,844,389Towards broader-spectrum direct-acting antivirals against RNA viruses.Nat Rev Microbiol2026https://conductscience.org/library/papers/42844389PubMed
42,568,525From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42568525PubMed
42,513,991A Structural View of Influenza Virus Ribonucleoprotein Complex and Its Functions.Microorganisms2026https://conductscience.org/library/papers/42513991PubMed
42,434,556A scoping review of influenza RdRp-targeting inhibitors: mechanisms, clinical translation, and emerging challenges.Front Microbiol2026https://conductscience.org/library/papers/42434556PubMed
42,427,235Preclinical characterization of HEC116094, an oral inhibitor of the influenza A virus polymerase PB2 subunit.Emerg Microbes Infect2026https://conductscience.org/library/papers/42427235PubMed
41,685,158Anti-influenza drugs targeting trimeric RNA polymerase complex: From development to clinics.Acta Pharm Sin B2026https://conductscience.org/library/papers/41685158PubMed
41,187,142Antibacterial and antiviral potential of harmalacidine hydrochloride, a β-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus.PLoS One2025https://conductscience.org/library/papers/41187142PubMed
41,105,303Antiviral strategies against H5N1: current options and emerging therapeutics.Infection2026https://conductscience.org/library/papers/41105303PubMed
40,864,651CRISPR with Transcriptional Readout reveals influenza transcription is modulated by NELF and can precipitate an interferon response.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40864651PubMed
40,839,799Making Sense of Heteroatom Effects in π-π Interactions.J Am Chem Soc2025https://conductscience.org/library/papers/40839799PubMed
40,484,321High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay.Antiviral Res2025https://conductscience.org/library/papers/40484321PubMed
40,439,048Revisiting the Hunter-Sanders Model for π-π Interactions.J Am Chem Soc2025https://conductscience.org/library/papers/40439048PubMed
40,146,533Stacking Interactions of Druglike Heterocycles with Nucleobases.J Chem Inf Model2025https://conductscience.org/library/papers/40146533PubMed
39,992,105A phase I, single-center, randomized, open-label, three-period crossover study to evaluate the drug-drug interaction between ZSP1273 and oseltamivir in healthy Chinese subjects.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/39992105PubMed
39,775,042Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial.Nat Med2025https://conductscience.org/library/papers/39775042PubMed
39,163,780Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling.Eur J Med Chem2024https://conductscience.org/library/papers/39163780PubMed
38,681,787Latest developments in early diagnosis and specific treatment of severe influenza infection.J Intensive Med2024https://conductscience.org/library/papers/38681787PubMed
38,551,343Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".mBio2024https://conductscience.org/library/papers/38551343PubMed
38,283,223Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery.RSC Med Chem2024https://conductscience.org/library/papers/38283223PubMed
38,005,857Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2.Viruses2023https://conductscience.org/library/papers/38005857PubMed

See all 99 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25019388

GET https://conductscience.org/api/papers/v1/25019388/authors?page=2